• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.

作者信息

Klinkenberg-Knol E C, Jansen J B, Lamers C B, Nelis F, Meuwissen S G

机构信息

Dept. of Gastroenterology, Free University Hospital, Amsterdam, The Netherlands.

出版信息

Scand J Gastroenterol. 1990 Nov;25(11):1144-50. doi: 10.3109/00365529008998547.

DOI:10.3109/00365529008998547
PMID:1980377
Abstract

To study the effects of sudden withdrawal of long-term maintenance therapy with omeprazole for up to 4 years, 14 patients with resistant reflux oesophagitis were asked to stop their treatment temporarily. Ten days after withdrawal median basal acid output had increased significantly (p = 0.01) from 0 (range, 0-1.18) on day 1 to 1.95 (range, 0-8.45) mmol/h on day 10. Median serum gastrin levels were raised during treatment with omeprazole but decreased significantly from 166 to 42 ng/l within the 10 days of the study (p = 0.01). The median integrated gastrin response after meal stimulation decreased significantly (p less than 0.001) from 758.6 ng/l on day 1 to 267.9 ng/l on day 10. On day 10 after withdrawal of omeprazole all patients had endoscopic and symptomatic evidence of recurrent oesophagitis. Reflux patients receiving maintenance treatment with omeprazole for up to 4 years showed prompt normalization of serum gastrin levels and return of gastric acid production within 10 days after stopping the treatment. Consequently, there was a fast recurrence of aggravation of reflux symptoms and oesophagitis.

摘要

相似文献

1
Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.
Scand J Gastroenterol. 1990 Nov;25(11):1144-50. doi: 10.3109/00365529008998547.
2
Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.奥美拉唑在治疗对H2受体拮抗剂耐药的反流性食管炎中的应用。
Scand J Gastroenterol Suppl. 1989;166:88-93; discussion 94. doi: 10.3109/00365528909091251.
3
Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.奥美拉唑长期治疗难治性反流性食管炎:疗效与安全性。
Ann Intern Med. 1994 Aug 1;121(3):161-7. doi: 10.7326/0003-4819-121-3-199408010-00001.
4
High doses of ranitidine in patients with reflux oesophagitis.反流性食管炎患者使用高剂量雷尼替丁的情况。
Scand J Gastroenterol Suppl. 1990;178:42-6. doi: 10.3109/00365529009093149.
5
Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.奥美拉唑对反流性食管炎的长期维持治疗。对H2受体阻滞剂抵抗性食管炎患者的前瞻性研究。
Dig Dis Sci. 1991 May;36(5):552-7. doi: 10.1007/BF01297018.
6
Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole.恩前列素对长期接受奥美拉唑治疗患者血清胃泌素及胃蛋白酶原A和C水平的影响。
Aliment Pharmacol Ther. 1994 Apr;8(2):221-7. doi: 10.1111/j.1365-2036.1994.tb00282.x.
7
Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Aliment Pharmacol Ther. 1990 Apr;4(2):145-55. doi: 10.1111/j.1365-2036.1990.tb00459.x.
8
Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.对H2受体拮抗剂治疗无效的反流性食管炎患者使用奥美拉唑治疗的前瞻性评估。
Aliment Pharmacol Ther. 1990 Dec;4(6):593-9. doi: 10.1111/j.1365-2036.1990.tb00507.x.
9
Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis.长期持续与隔日服用奥美拉唑疗法对反流性食管炎患者血清胃泌素的影响
J Clin Gastroenterol. 2001 Jul;33(1):32-5. doi: 10.1097/00004836-200107000-00008.
10
Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.奥美拉唑用于治疗对H2受体拮抗剂无反应且不宜手术的重度反流性食管炎患者。
Acta Gastroenterol Belg. 1990 Sep-Dec;53(5-6):573-84.

引用本文的文献

1
Healing of severe esophagitis improves esophageal peristaltic dysfunction.严重食管炎的愈合可改善食管蠕动功能障碍。
Dig Dis Sci. 1999 Jan;44(1):125-33. doi: 10.1023/a:1026614519572.
2
Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.西沙必利对食管炎复发的影响。一项在使用抗分泌药物治愈的患者中进行的多国、安慰剂对照试验。意大利欧洲西沙必利试验研究者。
Dig Dis Sci. 1993 Mar;38(3):551-60. doi: 10.1007/BF01316514.
3
Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.
奥美拉唑治疗胃肠道疾病的风险效益评估。
Drug Saf. 1994 Jan;10(1):66-82. doi: 10.2165/00002018-199410010-00005.
4
Pharmacological management of gastro-oesophageal reflux disease.胃食管反流病的药物治疗
Drugs. 1995 May;49(5):695-710. doi: 10.2165/00003495-199549050-00005.
5
Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.奥美拉唑。其药理学及在酸相关性疾病治疗应用的最新综述。
Drugs. 1991 Jul;42(1):138-70. doi: 10.2165/00003495-199142010-00008.
6
Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.奥美拉唑对反流性食管炎的长期维持治疗。对H2受体阻滞剂抵抗性食管炎患者的前瞻性研究。
Dig Dis Sci. 1991 May;36(5):552-7. doi: 10.1007/BF01297018.